All In Biotech

Drug Trial Radar · NCT06518291

COMPARISON OF NITROFURANTOIN WITH FOSFOMYCIN in TREATING CYSTITIS IN WOMEN

Last checked: Nov 19, 2026Latest source record: Jul 24, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 392 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

392

Planned (sponsor's estimate)

Start

Jan 2025

Primary completion

Jun 2025

Study completion Jun 2025

Sponsor

Lead sponsor
Shalamar Institute of Health SciencesAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 24, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years, up to 83 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Fosfomycin and nitrofurantoin are increasingly being prescribed in outpatients for the oral treatment of urinary tract infection (UTI). The newest guidelines for empirical treatment of women with uncomplicated urinary tract infections (UTIs) advise clinicians to choose among three venerable antibiotics: trimethoprim-sulfamethoxazole, nitrofurantoin, and fosfomycin. Although both nitrofurantoin and fosfomycin have shown efficacy against most urinary pathogens, no recent head-to-head comparisons have been reported. So, this study will be conducted to compare effectiveness of both drugs.

Conditions

  • Urinary Tract Infections

Interventions

  • Nitrofurantoin 100 MGDrug

    Comparing two drugs in UTI treatment

  • FosfomycinDrug

    treatment of UTI

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. clinical response following completion of therapy by historyTime frame: 7 days

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.